The present invention discloses indicator fluids, reference indicator fluid, and usage thereof, and systems and methods for assessing movement of molecular substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a human cranio-spinal cavity. Indicator fluid moving from the cerebrospinal fluid compartment enables measurements of levels of indicator fluid in blood or urine and assessment of the cranio-spinal cavity's ability to remove molecular substances. The indicator fluids may be contrast agents used for imaging, such as by computed tomography imaging, and magnetic resonance imaging, or imaging utilizing radioactive substances by positron emission tomography, single-photon emission computed tomography or scintigraphy. Using these imaging modalities, the invention describes indicator fluids, systems and methods enabling assessment of movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity, and from the human cranio-spinal cavity to lymphatic pathways or kidneys.

The medical information display apparatus includes an image acquisition unit that acquires a first brain image which is a brain image of a subject captured at a first time point and a second brain image captured at a second time point later in time than the first time point, a registration unit that performs registration between the first and the second brain image, an image analysis unit that extracts a first cavity region and a second cavity region from the first brain image and the second brain image, respectively, a display unit, and a display controller displays, a cavity expansion part included in a first non-cavity region, which is a region other than the first cavity region, and included in the second cavity region in a distinguishable manner from a region other than the cavity expansion part from a result of the registration between the first and second brain image.

The present invention is a Miniature Vein Enhancer that includes a Miniature Projection Head. The Miniature Projection Head may be operated in one of three modes, AFM, DBM, and RTM. The Miniature Projection Head of the present invention projects an image of the veins of a patient, which aids the practitioner in pinpointing a vein for an intravenous drip, blood test, and the like. The Miniature projection head may have a cavity for a power source or it may have a power source located in a body portion of the Miniature Vein Enhancer. The Miniature Vein Enhancer may be attached to one of several improved needle protectors, or the Miniature Vein Enhancer may be attached to a body similar to a flashlight for hand held use. The Miniature Vein Enhancer of the present invention may also be attached to a magnifying glass, a flat panel display, and the like.

The present invent is directed to a diagnostic platform that can be used to provide efficient and safe healthcare. The diagnostic platform has a database and back-end server for storing and processing healthcare information, a display for conveying information to a user, and a user interface for interacting with a user that includes an avatar that can assist the user. A diagnostic device including a temperature sensor, a heart rate sensor, a pulse oximeter sensor; and a stethoscope may be used to obtain healthcare information from the user. A system of electronic keys and electronic key readers may be integrated into the diagnostic platform to provide contract tracing functionality.

A communication device comprising: a first unit having a first antenna, a second antenna, and a first signal transmitting and receiving circuitry; a second unit having a third antenna, a fourth antenna, and a second signal transmitting and receiving circuitry, wherein the second unit is located in proximity to the first unit; and wherein the second unit is capable of receiving signals at a first signal frequency, down converting the signals to a second signal frequency, and relaying the signals through a barrier to the first unit. Wherein the first signal frequency is in the millimeter wave range and the second signal frequency is in the microwave range.

A system for measuring blood oxygenation levels and capillary refill time (CRT) of a user includes a camera configured to capture a video stream that includes a series of images representing a process of first squeezing a fingernail of the user to a blanched state, and then releasing to a resting state, and a Convolutional Neural Network (CNN) based processing unit configured to process an input image to create a two-dimensional representation of features, remove spatial relationships in the two-dimensional representation, generate non-spatial metadata, identify the fingernail in the resting state, and regions within a static image of the fingernail, and configured to generate a blood oxygenation value, and a measurement confidence level, and generate a CRT value of the user by applying the blood oxygenation value, and the measurement confidence level to a series of images captured by the camera over time.

Imaging methods aid a user in understanding relative depths of objects or topography within a field of view. In one method, image data is gathered using 3D image sensors, while illumination of an area of interest is alternated with projection of a pattern onto the area of interest. The captured image data is used to display a 3D true color image; a monochrome grid on surfaces of the area of interest; a 3D true color image with a monochrome grid on surfaces of the area of interest; a 2D or 3D false color image where different colors identify different depths of regions of the area of interest; and/or a 2D or 3D true color image of an area of interest with features in the area of interest located a first depth relative to the image sensors highlighted with a common color. In another method, 3D image data is used to generate a 2D image that highlights features at a common depth using the same color.

A method for applying cold atmospheric plasma treatment to target tissue comprising the steps of treating a patient with a pharmaceutical for suppressing apolipoprotein E genes, selecting through a graphical user interface a particular soft tissue sarcoma cell line associated with target tissue, retrieving, with said computing device, settings data associated with said selected soft tissue sarcoma cell line from a database of cell line data and associated settings data in a storage, and applying, with said computing device, said retrieved settings data to a cold atmospheric plasma system.

This present invention relates to a body scanning device that is capable of both capturing, displaying and/or transmitting to remote locations the vital signs of a user and a preliminary diagnosis. More specifically, the body scanning device scans a palm of an individual using an electrical pulse to read and interpret the individual's vital signs, as well as allowing the user to input body parameter information such as sex, height, weight, etc. The body scanning device provides the individual with diagnostic questions, and an overall diagnosis based on the scan. The body scanning device is further comprised of Wi-Fi and/or Bluetooth capabilities.

Various embodiments provide systems and methods for identifying impairment using measurement devices.